Arcus Biosciences RCUS
NYSE RCUS
$24.46 -0.76 (-3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Selling, General & Administrative (2017 - 2026)

Updated

Arcus Biosciences (RCUS) posted Selling, General & Administrative of $24 million for Q2 2026, down 17.2% from $29 million a year earlier and down 17.2% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Selling, General & Administrative (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Arcus Biosciences was $106 million, down 7.8% year-over-year; for FY2025, it came in at $110 million, down 8.3% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 20.7% (FY2020 to FY2025).
  • In prior years, Arcus Biosciences' Selling, General & Administrative was $120 million in FY2024 (+2.6%), $117 million in FY2023 (+12.5%), $104 million in FY2022 (+44.4%) and $72 million in FY2021 (+67.4%).
  • Quarterly Selling, General & Administrative has run from a low of $16.34 million in Q3 2021 to a high of $32 million in Q1 2024 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in 1 of the last eight quarters, with an average decline of 6.3%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 71.9%; the weakest was Q2 2026, with a decline of 17.2%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $29 million (Q1 2026), $26 million (Q4 2025) and $27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Arcus Biosciences 3.20 Bn -133.06 Mn - 24.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.00 Mn
Mar 31, 2026 29.00 Mn
Dec 31, 2025 26.00 Mn
Sep 30, 2025 27.00 Mn
Jun 30, 2025 29.00 Mn
Mar 31, 2025 28.00 Mn
Dec 31, 2024 28.00 Mn
Sep 30, 2024 30.00 Mn
Jun 30, 2024 30.00 Mn
Mar 31, 2024 32.00 Mn
Dec 31, 2023 29.00 Mn
Sep 30, 2023 30.00 Mn
Jun 30, 2023 28.00 Mn
Mar 31, 2023 30.00 Mn
Dec 31, 2022 28.00 Mn
Sep 30, 2022 26.00 Mn
Jun 30, 2022 26.00 Mn
Mar 31, 2022 24.00 Mn
Dec 31, 2021 23.01 Mn
Sep 30, 2021 16.34 Mn
API Access

Arcus Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RCUS&period=max&api_key=YOUR_API_KEY